SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599901-23-000029
Filing Date
2023-05-09
Accepted
2023-05-09 16:10:26
Documents
14
Period of Report
2023-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rna-20230509.htm   iXBRL 8-K 33967
2 EX-99.1 rna-20230509xexx991.htm EX-99.1 61300
6 gfnzizaxnpmk000001.jpg GRAPHIC 206622
  Complete submission text file 0001599901-23-000029.txt   493976

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rna-20230509.xsd EX-101.SCH 1929
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rna-20230509_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rna-20230509_pre.xml EX-101.PRE 13065
8 EXTRACTED XBRL INSTANCE DOCUMENT rna-20230509_htm.xml XML 11268
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 23902065
SIC: 2834 Pharmaceutical Preparations